IL2-caspase3 chimeric protein controls lymphocyte reactivity by targeted apoptosis, leading to amelioration of experimental autoimmune encephalomyelitis.

Source:http://linkedlifedata.com/resource/pubmed/id/19631295

Download in:

View as

General Info

PMID
19631295